Integrating Clinical and Translational Research Networks-Building Team Medicine - Series 2

The previous Special Issue of the Journal of Clinical Medicine, 'Integrating Clinical and Translational Research Networks-Building Team Medicine', which highlighted our collective experience from the City of Hope and was published in 2020, was a huge success. Buoyed by the enthusiastic res...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
n/a
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication
LEADER 05965namaa2201525uu 4500
001 doab113918
003 oapen
005 20230911
006 m o d
007 cr|mn|---annan
008 230911s2023 xx |||||o ||| 0|eng d
020 |a 9783036584720 
020 |a 9783036584737 
020 |a books978-3-0365-8473-7 
024 7 |a 10.3390/books978-3-0365-8473-7  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJCL  |2 bicssc 
720 1 |a Salgia, Ravi  |4 edt 
720 1 |a Kulkarni, Prakash  |4 edt 
720 1 |a Kulkarni, Prakash  |4 oth 
720 1 |a Salgia, Ravi  |4 oth 
245 0 0 |a Integrating Clinical and Translational Research Networks-Building Team Medicine - Series 2 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 online resource (230 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a The previous Special Issue of the Journal of Clinical Medicine, 'Integrating Clinical and Translational Research Networks-Building Team Medicine', which highlighted our collective experience from the City of Hope and was published in 2020, was a huge success. Buoyed by the enthusiastic response from our peers and colleagues, we have embarked on bringing out Volume 2. The basic theme is the same-namely, integrating academic medical centers with the clinical network in various geographic locations to ensure that all patients, regardless of their physical proximity to major medical institutions, can benefit from recent clinical advances. As in the previous volume on the importance of including basic research scientists, our aim here is to highlight translational research approaches that leverage the combined knowledge, skills, experience, expertise, and vision of clinicians in academic medical centers, their affiliated community centers, and hospitals, together with those of basic research scientists. However, here we also strive to include bioinformaticians and data scientists. We look forward to sharing our team medicine experience with our colleagues around the world and trust that they will find the approach described in the articles included in this Special issue useful for guiding their approaches for treating cancer patients. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine and Nursing  |2 bicssc 
650 7 |a Oncology  |2 bicssc 
653 |a adaptive therapy 
653 |a advanced soft tissue sarcoma 
653 |a artificial intelligence 
653 |a ATM mutation 
653 |a brain metastases 
653 |a BRIP1 mutation 
653 |a cancer disparities 
653 |a cancer prevention 
653 |a cancer systems biology 
653 |a care satisfaction 
653 |a cisplatin 
653 |a City of Hope 
653 |a clinical care network 
653 |a clinical network systems biology 
653 |a clinical trials 
653 |a collaboration 
653 |a colorectal cancer survivor 
653 |a combinational therapy 
653 |a community clinical network 
653 |a community practice 
653 |a complex case discussions 
653 |a continuous therapy 
653 |a cutaneous cancers 
653 |a decision support 
653 |a delivery of health care 
653 |a drug resistance 
653 |a drug tolerance 
653 |a eco-evolutionary 
653 |a EGFR 
653 |a emergency utilization 
653 |a endometrial cancer 
653 |a epigenetics 
653 |a genetic/nongenetic 
653 |a genomic-driven 
653 |a group behavior 
653 |a gut microbiome 
653 |a IDPs 
653 |a imaging 
653 |a immune checkpoint inhibitors 
653 |a immunotherapy 
653 |a implementation 
653 |a implementation science 
653 |a integration 
653 |a integrative oncology 
653 |a intermittent therapy 
653 |a intrinsically disordered proteins 
653 |a LDCT 
653 |a leptomeningeal metastases 
653 |a low dose Ct scans 
653 |a lung cancer screening 
653 |a mathematical modeling 
653 |a melanoma 
653 |a metastasis-directed therapy 
653 |a Midwest Sarcoma Trials Partnership 
653 |a minority health 
653 |a multidisciplinary tumor board 
653 |a n/a 
653 |a NET VITALS 
653 |a neuroendocrine tumors 
653 |a non-small cell lung cancer 
653 |a Olaparib 
653 |a oligometastatic 
653 |a oncology 
653 |a oncology pathways 
653 |a oncolytic virotherapy 
653 |a pandemic 
653 |a PARP inhibition 
653 |a pathologic complete response 
653 |a pathways to success 
653 |a personalized medicine 
653 |a phase 1 
653 |a phenotype switching 
653 |a POLE mutation 
653 |a precision medicine 
653 |a prostate cancer 
653 |a PSMA PET 
653 |a RAD51C mutation 
653 |a renal cell carcinoma 
653 |a sarcoma treatment 
653 |a SARS-CoV-2 
653 |a self-assessment 
653 |a smoking cessation 
653 |a subspecialty expertise 
653 |a T-VEC 
653 |a targeted therapy 
653 |a team medicine 
653 |a Team Medicine 
653 |a TMB high 
653 |a tobacco control 
653 |a translational research 
653 |a tumor board 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/113918  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/7761  |7 0  |z Open Access: DOAB, download the publication